The Potential of Senescence as a Target for Developing Anticancer Therapy

Area of Science:

• Oncology
• Cell Biology
• Molecular Biology

Background:

• Cellular senescence is a stress response with complex roles in cancer, acting as both a tumor suppressor and promoter.
• The senescence-associated secretory phenotype (SASP) contributes to tumorigenesis and therapeutic resistance.
• Understanding senescence mechanisms is crucial for developing novel cancer treatments.

Purpose of the Study:

• To review the mechanisms of senescence induction.
• To elucidate the multifaceted roles of SASP in cancer progression and treatment resistance.
• To explore the involvement of autophagy, HDACs, and miRNAs in senescence.

Main Methods:

• Literature review of senescence induction pathways.
• Analysis of SASP functions in tumorigenesis and therapy.
• Discussion of regulatory roles of autophagy, HDACs, and miRNAs.

Main Results:

• Senescence can suppress tumors but also promote resistance and progression via SASP.
• SASP effects are context-dependent, exhibiting both pro- and anti-tumorigenic activities.
• Autophagy, HDACs, and miRNAs are key regulators of senescence.

Conclusions:

• Targeting senescence, particularly through HDACs and miRNAs, can overcome therapeutic resistance.
• Senescence induction is a potent strategy to inhibit cancer cell proliferation.
• Modulating senescence holds significant therapeutic potential in oncology.